| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/1993 | WO1993006218A2 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
| 04/01/1993 | WO1993006216A1 Fusion proteins targeted to lysosomes, for the treatment of aids |
| 04/01/1993 | WO1993006215A1 Receptor of the thyroid/steroid hormone receptor superfamily |
| 04/01/1993 | WO1993006214A1 Chimeric and/or growth-restricted flaviviruses |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006135A1 Diagnosing and treating autoimmune disorders |
| 04/01/1993 | WO1993006134A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | WO1993006133A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 04/01/1993 | WO1993006132A1 Modified peptide derivatives |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993006129A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 04/01/1993 | WO1993006128A1 Tnf antagonist peptides |
| 04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 04/01/1993 | WO1993006123A1 Human cyclin e |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993005817A1 Transgenic mhc class i and class ii antigen-deficient mammals |
| 04/01/1993 | WO1993005814A1 Competitive inhibition of t cell-b cell interactions |
| 04/01/1993 | WO1993005813A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 04/01/1993 | WO1993005812A1 Method to induce cytotoxic t lymphocytes specific for a broad array of hiv-1 isolates using hybrid synthetic peptides |
| 04/01/1993 | WO1993005807A2 Erythropoietin potentiating agents and methods for their use |
| 04/01/1993 | WO1993005803A1 Anti-inflammatory selectin inhibitors |
| 04/01/1993 | WO1993005802A1 Biologically active amphiphilic peptide compositions and uses therefor |
| 04/01/1993 | WO1993005797A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 04/01/1993 | WO1993005786A1 Novel gabaa receptor with steroid binding sites |
| 04/01/1993 | WO1993005774A1 Complexes of anthracycline antibiotics with polyunsaturated fatty acids in lipid emulsions |
| 04/01/1993 | WO1993005751A2 Osteogenic proteins in the treatment of bone deseases |
| 04/01/1993 | WO1993005657A1 NOVEL BACILLUS THURINGIENSIS ISOLATE DENOTED B.t.PS158C2, ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING LEPIDOPTERAN-ACTIVE TOXINS |
| 04/01/1993 | WO1993003755A3 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | WO1992020802A3 Novel bacillus thuringiensis isolates active against hymenopteran pests and genes encoding hymenopteran-active toxins |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 04/01/1993 | CA2120036A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies produced therefrom and methods of use thereof |
| 04/01/1993 | CA2119447A1 Cdna encoding a dopamine transporter and protein encoded thereby |
| 04/01/1993 | CA2119379A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 04/01/1993 | CA2119013A1 Hepatitis c assay |
| 04/01/1993 | CA2119003A1 Factors for the cellular functional regulation and biological applications thereof |
| 04/01/1993 | CA2118939A1 Biologically active amphiphilic peptide compositions and uses thereof |
| 04/01/1993 | CA2118938A1 Novel gabaa receptor with steroid binding sites |
| 04/01/1993 | CA2118595A1 Modified peptide derivatives |
| 04/01/1993 | CA2116227A1 Annexin xi |
| 04/01/1993 | CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | CA2115566A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 04/01/1993 | CA2115452A1 Receptor of the thyroid/steroid hormone receptor superfamily |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534812A1 Process for purifying factor VIII and preparations so obtained |
| 03/31/1993 | EP0534764A1 Protein-dimeric polysaccharide conjugate vaccine |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534705A2 Expression of low molecular weight recombinant polypeptides |
| 03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
| 03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
| 03/31/1993 | EP0534526A1 Treponema hyodysenteriae vaccine |
| 03/31/1993 | EP0534383A2 Process for preparing human coagulation factor VIII protein complex |
| 03/31/1993 | EP0534102A1 Human cytomegalovirus specific peptides and use thereof |
| 03/31/1993 | EP0533946A1 Adsorbed cellular fibronectin and process for separating and purifying fibronectins |
| 03/31/1993 | EP0533913A1 Novel endopeptidase |
| 03/31/1993 | EP0533862A1 Recombinant human factor viii derivatives |
| 03/31/1993 | EP0533854A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
| 03/31/1993 | EP0533838A1 Nucleic acid ligands |
| 03/31/1993 | EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 03/31/1993 | EP0533795A1 Composition of and treatment with biologically active peptides having d-amino acid residues |
| 03/31/1993 | EP0533779A1 Determination of polypeptides and proteins in solutions and biological fluids |
| 03/31/1993 | EP0479799A4 Wound healing |
| 03/31/1993 | EP0470976B1 Processes and compositions for the isolation of human relaxin |
| 03/31/1993 | EP0466854A4 T cell growth factor |
| 03/31/1993 | EP0281604B1 Single polypeptide chain binding molecules |
| 03/31/1993 | EP0269729B1 Method of preparing toxoid |
| 03/31/1993 | EP0253870B1 Method for producing factor viii:c-type proteins |
| 03/31/1993 | CN1070484A Immunaassay for simultaneous detection of HIV-1, HIV-2, HTLV-I and HTLV-II antibodies |
| 03/31/1993 | CN1070310A Regeneration and transformation of cotton |
| 03/31/1993 | CN1070309A Regeneration and transformation of cotton |
| 03/31/1993 | CA2079291A1 Activities of heparin binding neurite-outgrowth promoting factor |
| 03/31/1993 | CA2079290A1 Activities of mk protein |
| 03/30/1993 | US5198542 Dna encoding a pitvitary adenylate cyclase activating protein and use thereof |
| 03/30/1993 | US5198541 Dna encoding bactericidal/permeability-increasing proteins |
| 03/30/1993 | US5198538 Method for producing immunosuppressive agents |
| 03/30/1993 | US5198537 Immunogens for immunoassay |
| 03/30/1993 | US5198536 Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides |
| 03/30/1993 | US5198535 Protective malaria sporozoite surface protein immunogen and gene |
| 03/30/1993 | US5198533 Decapeptides |
| 03/30/1993 | US5198428 Macrophage cytotoxin compositions and methods of preparation |
| 03/30/1993 | US5198424 Functionally active selectin-derived peptides |
| 03/30/1993 | US5198423 Inhibition of angiogenesis, wound healing |
| 03/30/1993 | US5198422 Complex With Aromatic Aldehyde, Sustained Release |
| 03/30/1993 | US5198420 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
| 03/30/1993 | US5198361 Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods |
| 03/30/1993 | US5198359 Recombinant protein receptor for il-2 |
| 03/30/1993 | US5198356 Monophenotypic in vitro cell lines of megakaryocytic lineage, products produced thereby and methods |
| 03/30/1993 | US5198352 Preparation of antibacterial compositions from glycopeptides |
| 03/30/1993 | US5198350 Viricides |
| 03/30/1993 | US5198349 Expression vectors with gene coding |
| 03/30/1993 | US5198348 Yeast cell transformation vectors, Saccharomyces |
| 03/30/1993 | US5198347 Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor |
| 03/30/1993 | US5198346 Generation and selection of novel DNA-binding proteins and polypeptides |
| 03/30/1993 | US5198345 Aspergillus, DNA construct for transforming host |
| 03/30/1993 | US5198344 DNA sequence that encodes the multidrug resistance gene |
| 03/30/1993 | US5198342 DNA encoding IgA Fc receptors |
| 03/30/1993 | US5198224 Polypeptide thin film |
| 03/30/1993 | US5197973 Polypeptide |